Glofitamab (Lunsumio)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Glofitamab (Lunsumio), covering 2024-10-24 to 2024-10-24. Get the full timeline:
Most recent: Clinical Trial Update: The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study